Replies to post #16521 on Oncolix Inc. (fka ONCX)

[DayDreeming]

Not compensated now, but compensated soon. Where will the $$$$ will come from to compensate directors in the future if no revenue...lol

Biovectra also owns an equity interest in ONCX and their former CEO serves as an uncompensated member of the BOD.

"Director Compensation
During 2017 and 2016, the directors of the Company were not compensated for their services as directors and it is not expected that the directors will receive compensation in 2018, except as described below. Upon his appointment to the Board, Dr. Holaday was granted a warrant to acquire 900,000 shares of Common Stock at $0.09 per share. This warrant was initially exercisable for 1/3 of the shares, and 1/3 are exercisable on the first and second anniversary. The warrant expires on November 30, 2022. Dr. Holaday will also be paid $1,000 per month of service. The Company has no other formal arrangement pursuant to which directors are compensated for their services in their capacity as directors, but expects to adopt a policy in 2018 for independent directors. Directors are reimbursed for reasonable out of pocket expenses incurred."

Source 424B3 dated 2/9/18